Skip to main content
SpringerLink
Log in

Neue Devices zur Reparatur von Herzklappen

Behandlung der Aorten- und Mitralklappe

  • CME Fortbildung
  • Published:
CME Aims and scope

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Zusammenfassung

Kathetergestützte Verfahren zur Behandlung von Herzklappenerkrankungen haben sich in den letzten Jahren rasant entwickelt. Der prognostische Nutzen einer kathetergestützten Aortenklappenimplantation bei hohem sowie intermediärem operativen Risiko wurde bereits in randomisierten Studien belegt. Aktuell ist ein Trend zur Behandlung von Patienten mit niedrigem Risiko zu verzeichnen. Zudem erleben interventionelle Verfahren zur Behandlung der Mitralklappe eine dynamische Entwicklung.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2
3

Literatur

  1. Iung B. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231–43

    Article  Google Scholar 

  2. Gaede L, Blumenstein J, Liebetrau C et al. Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J. 2017; https://doi.org/10.1093/eurheartj/ehx688

    Google Scholar 

  3. Vahl TP, Kodali SK, Leon MB. Transcatheter Aortic Valve Replacement 2016: A Modern-Day “Through the Looking-Glass” Adventure. J Am Coll Cardiol. 2016;67:1472–87

    Article  Google Scholar 

  4. Frangieh AH, Ott I, Michel J et al. Standardized Minimalistic Transfemoral Transcatheter Aortic Valve Replacement (TAVR) Using the SAPIEN 3 Device: Stepwise Description, Feasibility, and Safety from a Large Consecutive Single-Center Single-Operator Cohort. Structural Heart. 2017;1:169–78

    Article  Google Scholar 

  5. Leon MB, Smith CR, Mack MJ et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374:1609–20

    Article  CAS  Google Scholar 

  6. Reardon MJ, Van Mieghem NM, Popma JJ et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017;376:1321–31

    Article  Google Scholar 

  7. Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607

    Article  CAS  Google Scholar 

  8. Thyregod HGH, Steinbrüchel DA, Ihlemann N et al. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol. 2015;65:2184–194

    Article  Google Scholar 

  9. Baumgartner H, Falk V, Bax JJ et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91

    Article  Google Scholar 

  10. Siemieniuk RA, Agoritsas T, Manja V et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis. BMJ. 2016;354:i5130

    Article  Google Scholar 

  11. Ott I, Greenbaum AB, Schunkert H et al. First use of an expandable sheath and transcaval access for transcatheter Edwards SAPIEN 3 aortic valve implantation. EuroIntervention. 2015;11:782–4

    Article  Google Scholar 

  12. Greenbaum AB, Babaliaros VC, Chen MY et al. Transcaval Access and Closure for Transcatheter Aortic Valve Replacement: A Prospective Investigation. J Am Coll Cardiol. 2017;69:511–21

    Article  Google Scholar 

  13. Frangieh AH, Kasel AM. TAVI in Bicuspid Aortic Valves “Made Easy.” Eur Heart J. 2017;38:1177–81

    Article  Google Scholar 

  14. Dvir D, Webb JG, Bleiziffer S et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312:162–70

    Article  CAS  Google Scholar 

  15. Webb JG, Mack MJ, White JM et al. Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry. J Am Coll Cardiol. 2017;69:2253–62

    Article  Google Scholar 

  16. Barbanti M. Avoiding Coronary Occlusion and Root Rupture in TAVI — The Role of Pre-procedural Imaging and Prosthesis Selection. Interv Cardiol Rev. 2015;10:94–7

    Google Scholar 

  17. Arsalan M, Walther T. Durability of prostheses for transcatheter aortic valve implantation. Nat Rev Cardiol. 2016;13:360–7

    Article  CAS  Google Scholar 

  18. Makkar RR, Fontana G, Jilaihawi H et al. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med. 2015;373:2015–24

    Article  CAS  Google Scholar 

  19. Feldman T, Kar S, Elmariah S et al. Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. J Am Coll Cardiol. 2015;66:2844–54

    Article  Google Scholar 

  20. Buccheri S, Capodanno D, Barbanti M et al. A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation. Am J Cardiol. 2017;119:1443–9

    Article  Google Scholar 

  21. Puls M, Lubos E, Boekstegers P et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J. 2016;37:703–12

    Article  Google Scholar 

  22. Eleid MF, Whisenant BK, Cabalka AK et al. Early Outcomes of Percutaneous Transvenous Transseptal Transcatheter Valve Implantation in Failed Bioprosthetic Mitral Valves, Ring Annuloplasty, and Severe Mitral Annular Calcification. JACC Cardiovasc Interv. 2017;10:1932–42

    Article  Google Scholar 

  23. Babaliaros VC, Greenbaum AB, Khan JM et al. Intentional Percutaneous Laceration of the Anterior Mitral Leaflet to Prevent Outflow Obstruction During Transcatheter Mitral Valve Replacement: First-in-Human Experience. JACC Cardiovasc Interv. 2017;10:798–809

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse 36, 80636, München, Deutschland

    Tobias Rheude, Costanza Pellegrini &  Albert Markus Kasel

Authors
  1. Tobias Rheude
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Costanza Pellegrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Albert Markus Kasel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Albert Markus Kasel.

Additional information

Interessenkonflikt

Die Autoren erklären, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließen. TR und CP geben an, dass keine potenziellen Interessenkonflikte vorliegen. AMK ist Proctor und Consultant für Edwards Lifesciences. Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rheude, T., Pellegrini, C. & Kasel, A. Neue Devices zur Reparatur von Herzklappen. CME 15, 51–58 (2018). https://doi.org/10.1007/s11298-018-6421-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11298-018-6421-y

Schlüsselwörter

Search

Navigation